CONTINUING EDUCATION INFORMATION

ACPE Continuing Education

For pharmacists (CPE):

Continuing Education credits for pharmacists will be provided by Trinka Medical Publications. Attendees can earn up to 20.5 hours (2.05 CEUs) for attending Issues Panels, Forums, Symposiums, Plenary Sessions, Workshops, and Podium Sessions at the ISPOR 11th Annual International Meeting, up to 4 hours (0.4 CEUs) for each half-day short course, and up to 7.5 hours (0.75 CEUs) for each full day short course. Trinka Medical Publications is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education.

To receive continuing education credit, obtain the Continuing Education Program Summary Booklet at the ISPOR registration desk OR register online at http://www.ispor.org/members/events/closed.asp. Complete the booklet and return it to the ISPOR registration desk at the end of the meeting. Certificates of participation will be sent 4 – 6 weeks after submission of the booklet to those who register and complete the program evaluation. The fee for this service is $30 USD.

Session	ACPE Number	Sun	Mon	Tue	Wed	Total
Plenary Sessions	328-999-06-01-LO4		1.25	1	1.25	3.5
Issues Panels	328-999-06-02-LO4		1	1		2
Podium Presentations	328-999-06-03-LO4		1	1	2	4
Workshops	328-999-06-04-LO4		2	2		4
Forums/Symposiums	328-999-06-05-LO4	2	2	3		7
Total		2	7.25	8	3.25	20.5

SHORT COURSES

Course Name	Primary Faculty	Hours	ACPE#
Pharmacoeconomics for Decision-Makers	Lorne Basskin	7.5	328-999-06-010-LO4
Retrospective Database Analysis – Econometric Methods	William H. Crown	7.5	328-999-04-008-LO4
Modeling: Design and Structure of a Model	Marc Botteman	7.5	328-999-04-007-LO4
Finding and Extracting Cost Data	Judith O’Brien	4.0	328-999-04-004-LO4
Bayesian Analysis: Overview	Bryan Luce	4.0	328-999-06-011-LO4
Financial Impact / Cost of Illness	Josephine Mauskopf	4.0	328-999-04-055-LO4
Bayesian Analysis: Applications	Bryan Luce	4.0	328-999-04-060-LO4
Qualitative Methods for Quality of Life / Patient-Reported Outcomes	Carol Tishelman	4.0	328-999-06-012-LO4
Cost-Effectiveness Analysis alongside Clinical Trials	Scott Ramsey	4.0	328-999-06-013-LO4
Use of Real World Data in Outcomes Research	Diana Brixner	4.0	328-999-06-014-LO4
Bayesian Analysis: Advanced	Bryan Luce	4.0	328-999-04-015-LO4
Discrete Even Simulation for Economic Analyses	J. Jaime Caro	4.0	328-999-05-016-LO4
Advanced Quantitative Methods for Quality of Life / Patient-Reported Outcomes	Bruce Crawford	4.0	328-999-04-054-LO4
Elements of Pharmaceutical / Biotech Pricing I – Introduction	Jack Mycka	4.0	328-999-04-053-LO4
Statistical Considerations in Economic Evaluations	Henry Glick	4.0	328-999-04-014-LO4
Propensity Scores and Comorbidity Risk Adjustment	Fadia Shaya	4.0	328-999-06-015-LO4
Patient Registries: Overview and Application	Jeffrey Trotter	4.0	328-999-06-016-LO4
Utility Measures in Health Economics and Outcomes Research	F. Reed Johnson	4.0	328-999-04-005-LO4
Outcomes Research for Medical Device and Diagnostics	Seema Sonnad	4.0	328-999-06-017-LO4
Case Studies in Pharmaceutical / Biotech Pricing II – Advanced	Jack Mycka	4.0	328-999-06-018-LO4
Risk Assessment: Analysis and Management	Dennis Raisch	4.0	328-999-06-019-LO4